EmbeddingGemma 2: an open, lightweight multimodal embedding model
deepmind.google·6d ago
AI Engineering
Hacker News·Sep 8·5 min read
AI cancer cures slowed by chip shortage, says Arm boss
TL;DR
Rene Haas, CEO of Arm Holdings, believes AI will eventually discover cancer cures beyond human capability, but progress is hindered by a chip shortage. He expressed skepticism about future chip manufacturing in the UK.
✦ Why It Matters
Consider investing in AI research or chip manufacturing solutions to address current shortages.
Key Takeaways
- Invest in high-quality data collection for AI training.
- Monitor chip supply chain developments affecting AI projects.
- Explore AI applications in healthcare beyond traditional methods.
- Stay informed about advancements in AI-driven cancer research.
Full Summary
Rene Haas, the CEO of Arm Holdings, believes that artificial intelligence will eventually discover a cure for cancer that is beyond human reach. He acknowledges that modeling complex biological processes, such as how DNA markers are affected by cancer, is currently too intricate for both humans and existing AI systems.
However, as AI technology evolves and more accurate models are developed, breakthroughs in cancer treatment are expected. Haas also highlights the significant role of chip shortages in slowing down AI advancements, particularly in building data centers necessary for AI operations.
He notes that the future of medical AI will depend on the quality of data used for training rather than the size of the computing infrastructure. This shift could drastically reduce the time required to develop new treatments, ultimately benefiting patients.